AHR

American Healthcare REIT, Inc.

Fundamental data last updated:September 5, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Real Estate

industry

REIT - Healthcare Facilities

Exchange

NYSE

County of HQ

US

Next Earnings Date

Pending Announcement

Business Summary

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value. The company benefits from a fully integrated management platform comprised of more than one hundred experienced and skilled professionals, many of whom have worked together since 2006 and have successfully invested in and managed healthcare real estate through multiple market cycles. The management team has a proven track record, deep industry relationships and unparalleled insight into each of the company's assets having built and nurtured the company's international portfolio since its original property acquisition in 2014. The strength of the management team, coupled with the quality of the assets, has American Healthcare REIT poised to capitalize on compelling growth driven by powerful demographic trends. With its 19 million-square-foot, 312-building portfolio of medical office buildings, senior housing communities, skilled nursing facilities and integrated senior health campuses diversified across 36 states and the United Kingdom, the tri-party transaction was a critical step in ideally positioning American Healthcare REIT for a future public listing or IPO on a national stock exchange at the most opportune time. By listing the company's shares on a national exchange, we believe the company will gain greater access to attractive capital that will fuel future growth, broaden our investor base and also provide liquidity to our fellow stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC.

 


VALUATION

P/E

90.39

Market Cap ($M USD)

$9.33B

Forward P/E

N/A

PEG

N/A

PRICE TO SALES

3.94

PRICE TO BOOK

0.00

EV / EBITDA

-299.31

5-Year Average P/E

Free Cash Flow Yield

2.52%

DCF Value

$33.99

Graham Number

$473.26

Price to FCF

39.62

EV to FCF

-460.75

Earnings Yield

1.11%

FCF Yield

2.52%

DIVIDEND

Yield

2.07%

Annual Payout

$1.00

Payout Ratio

170.25%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

$0.54

Next Year EPS Growth Estimate

$0.00

Next Year Revenue Growth Estimate

$3.93B

Return on Equity (ROE)

0.01%

FREE CASH FLOW

Operating Margin

7.22%

Debt-to-Equity

0.48

Piotroski F-Score

5

Altman Z-Score

-0.32

Return on Invested Capital (ROIC)

0.00%

Current Ratio

0.00

Quick Ratio

0.00

Net Debt to EBITDA

-325.05

Interest Coverage

2.10

Gross Profit margin

9.57%

FCF PER SHARE

$1.26

REVENUE PER SHARE

$12.65

Gainseekers Quantitative Analysis

Summary

The market seems to be mispricing AHR American Healthcare REIT, Inc. relative to its intrinsic value. With a snapshot price significantly above its DCF Value, the stock appears overvalued. The astronomical Price/Earnings ratio of 96.55 suggests that investors are pricing in perfection, while the negative Altman Z-score raises red flags about financial distress. The Earnings Yield of just 1.04% is hardly enticing for value investors, indicating limited earnings potential relative to its price. Overall, the financial health is precarious, with the company trading at a premium that its fundamentals do not justify.

AI Exposure / Tech Reliance

Operating in the healthcare facilities sector, AHR is somewhat insulated from rapid AI disruptions. However, as a REIT, its ability to integrate tech advancements in property management and patient care could enhance operational efficiency. The company must leverage technology to maintain competitiveness in a rapidly evolving industry landscape.

The Bull Case

For the optimistic investor, AHR offers a few glimmers of hope. The Piotroski F-Score of 5 suggests moderate financial strength, while the Free Cash Flow Yield of 2.69% indicates some level of cash generation capability. Despite a meager ROIC of 0.00%, the company's operating margin of 7.22% hints at some pricing power. These metrics suggest that, with strategic management, there is potential for capital efficiency improvements.

The Bear Case

Yet, the bear case is hard to ignore. The Price/Book ratio of 0.0028 is shockingly low, indicating potential undervaluation, but the negative EV to EBITDA and Net Debt to EBITDA ratios signal severe operational inefficiencies. The company is technically overextended, trading close to its 52-week high, which could lead to a correction. The payout ratio of 123.57% is unsustainable, raising concerns about dividend viability and financial stability.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Buy

Average Analyst Price Target

$57.20

Institutional Ownership %

1-Year Beta

0.94

Insider Buying % (6 Mo)

Distance to 52-Week High

12.93%

Distance to 52-Week Low

29.70%

EARNINGS SURPRISE %

-19.20%

50-DAY SMA

$49.55

200-DAY SMA

$47.29

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.